Pfizer Q1 Earnings Beat Market, Revenues Miss; Sees FY25 Earnings Towards Top End Of View - Update
I'm PortAI, I can summarize articles.
Pfizer Inc. reported Q1 earnings that exceeded market expectations but showed a decline in revenues, missing analyst forecasts. The company maintained its fiscal 2025 guidance, expecting earnings between $2.80 and $3.00 per share and revenues of $61.0 to $64.0 billion. In Q1, Pfizer's profit was $2.967 billion ($0.52 per share), down from $3.115 billion ($0.55 per share) last year, while revenues fell 7.8% to $13.715 billion. The stock dropped 0.7% in pre-market trading.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: rttnews The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments